Immunovant Sciences Gmbh

This study is testing whether an investigational drug called IMVT-1402 can help adults with Graves' disease achieve normal thyroid levels without needing to continue their current thyroid medication. Researchers will compare IMVT-1402 against a placebo in 210 participants whose t…

This study is testing an investigational drug called IMVT-1402 for adults with moderate to severe primary Sjogren's disease, an autoimmune condition. The main goal is to see if the drug can reduce the overall activity of the disease compared to a placebo over 24 weeks. About 180 …

This study is testing whether an investigational drug called IMVT-1402 can help adults with Graves' disease achieve normal thyroid levels and stop their current thyroid medication. Researchers will compare the drug to a placebo in 240 participants over 26 weeks. The main goal is …

This study is testing whether an investigational drug called IMVT-1402 can safely reduce symptoms and improve daily life for adults with generalized myasthenia gravis, a chronic autoimmune disease that causes severe muscle weakness. About 231 participants with mild to severe symp…

This study is testing an investigational drug called IMVT-1402 for people with active cutaneous lupus, a condition causing skin rashes and lesions. About 56 participants will receive either the drug or a placebo via weekly injections for 12 weeks, followed by longer treatment per…

This study is testing whether an investigational drug called IMVT-1402 can help control Chronic Inflammatory Demyelinating Polyneuropathy (CIDP), a rare nerve disorder that causes weakness and disability. It will enroll 162 adults who are already on stable treatment for CIDP. Par…